Dabrafenib

Back to search
Scientific Name: Dabrafenib
Brand Name: Tafinlar
Company Owner: Not Available
Mechanism Of Action Dabrafenib is a competitive and selective BRAF inhibitor by binding to its ATP pocket.
Description of the Drug: Dabrafenib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
Protein Data Bank:
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08912